COMPANY PROFILE
SEARCH COMPANIES

Nanostring Technologies

Develops products that unlock genomic information from tissue and enable scientists and clinicians to create tests to improve patient care. Its first offering in the molecular diagnostics market, the Prosigna Breast Cancer Assay, received EU regulatory clearance last year. The company filed to go public in May 2013.

2013 STATISTICS

Rank:1783

3-year growth:215%

2012 Revenue:$23 million

2009 Revenue:$7.3 million

Web site:Nanostring.com

Employees:138

 

Founded:2003

Location:Seattle, WA

Industry:Health

2013 HONORS


#45

Top 100 Washington Companies

#40

Seattle Metro Area